We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SAABB:BXSaab AB Class B Analysis

Data as of 2026-03-10 - not real-time

SEK 667.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Saab’s share price is comfortably above its short‑term and medium‑term moving averages, signaling continued upward momentum. The relative strength index sits in a neutral zone, indicating that the stock is not yet overbought. A positive MACD histogram reinforces a bullish technical bias. Current price sits close to recent resistance while support remains well below, offering a clear upside target. Beta is low, suggesting the stock moves less than the broader market. Recent price swings have been pronounced, reflecting heightened short‑term volatility.
Fundamentally, the price‑to‑earnings multiple is markedly higher than the industry average, pointing to an overvalued valuation. The discounted cash‑flow estimate lies far beneath the market price, reinforcing the valuation gap. Revenue growth has been strong and cash balances are robust, supporting the company’s long‑term outlook. The dividend yield is modest and the payout ratio is low, indicating that the dividend is sustainable. The market sentiment index shows extreme greed, suggesting that optimism may be overstated. Overall, the stock presents a mixed picture of solid fundamentals tempered by an expensive price tag.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and price above moving averages
  • Neutral RSI suggests room for upside
  • Current price near resistance and valuation appears stretched

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth
  • Robust cash generation
  • Valuation gap may persist

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term defense contracts and market position
  • Sustainable dividend and low payout
  • Solid balance sheet with ample cash

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin7.98%
P/E Ratio57.1
ROE15.99%
ROA4.20%
Debt/Equity33.69
P/B Ratio8.3
Op. Cash FlowSEK12.1B
Free Cash FlowSEK707.8M
Industry P/E29.6

Technical Analysis

TrendNeutral
RSI54.7
SupportSEK 612.65
ResistanceSEK 701.75
MA 20SEK 647.30
MA 50SEK 656.12
MA 200SEK 546.12
MACDBullish
VolumeIncreasing
Fear & Greed Index79.82

Valuation

Fair ValueSEK 51.07
GradeOvervalued
TypeGrowth
Dividend Yield0.36%

Risk Assessment

Beta0.40
Volatility38.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.